Webinar: What can you do about PVCs in medical devices?

This webinar was presented live on Tuesday, June 26, 2018. Click below to watch on demand.

 

 

Polyvinylchloride (PVC) has long been a go-to material for medical device tubing and other healthcare products. But medtech companies need to think twice about its use now that the European Union is cracking down on the use of PVCs containing di(2-ethylhexyl)phthalate (DEHP) plasticizers, which have caused worries over their potential toxicity.

The E.U. is in the process of phasing in an expansion of its Restriction of Hazardous Substances (RoHS) directive and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) to include medical devices. The situation has medical device companies shifting to alternative formulations of PVC that don’t have DEHP, or even turning to non-PVC options, according to Larry Wallace, senior staff scientist at Spectrum Plastics Group.

Wallace in this webinar will go over the factors you need to consider if you’re switching to an alternative formulation of PVC, including the need to balance cost versus performance. He’ll also go over potential pitfalls to watch out for when moving away from PVCs altogether.

 

Featured Speakers:

Larry Wallace
Senior Staff Scientist
Spectrum Plastics Group

 

 

 

Chris Newmarker
Managing Editor
Medical Design and Outsourcing

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW